11 May 2021 Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance Member news
11 May 2021 Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme Member news
07 May 2021 CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers Member news
05 May 2021 Biocartis announces new collaboration with AstraZeneca to expand availability of Idylla™ EGFR biomarker testing among patients with lung cancer Member news
28 Apr 2021 Precirix partners with Evergreen to expand North American clinical trial supply Member news
23 Apr 2021 Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
